Vedic Lifesciences

Activities: Regulatory

Trending Articles

  1. Isospec launches analysis technology to identify unknown molecules The novel technology can facilitate the detection of trace amounts of unidentified molecules in nutraceutical formulations
  2. Kyowa Hakko’s IMMUSE powers Sensilab’s new IMMUNOFAR Biotic for enhanced immune support The incorporation of IMMUSE facilitates the strengthening of pDC functionality, promoting a healthy immune system
  3. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  4. Glanbia acquires Flavor Producers for $300m The acquisition adds significantly to Glanbia's Better Nutrition platform, introducing novel flavour offerings
  5. The role of traceability in the nutraceutical supply chain The exponential growth of the nutraceutical sector, combined with the unprecedented growth in online marketplaces, makes nutraceuticals highly vulnerable to vast counterfeiting...

Upcoming event

Vitafoods Europe

14–16 May 2024 | Exhibition | Palexpo, Geneva See all

Related Content

Ingredients

Optimise your next clinical trial for maximising your ROI

Vedic Lifesciences will be at Supplyside West 2022, booth #3127
Ingredients

Vedic Lifesciences study reveals effects of an oral herb seed oil product on inflammation

The clinical trial has illustrated the positive influence seed oil of Biota orientalis can have on inflammation and severe knee pain
Ingredients

Vedic Lifesciences begins enrolment for probiotic study on IBS

Past research has suggested that the inclusion of probiotics and post-biotics can support GI health and the growth of good bacteria
Research & Development

Vedic Lifesciences continues supplement studies through pandemic

In September 2020, the company concluded a multi-national study evaluating the impact of a botanical supplement on body composition
Subscribe now